Back to search results

Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation

Abroad (travel likely)RecruitingPHASE2

Conditions

Allogeneic Hematopoietic Cell Transplantation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Caitlin Cottrell) · Caitlin.cottrell@cchmc.org
    Contact: Principal Investigator (Parinda Mehta, MD)
Study leads

  • Parinda Mehta, MD

    Principal Investigator

    Children's Hospital Medical Center, Cincinnati

View source on ClinicalTrials.gov(opens in a new tab)